Episode 5 explores how testing reshaped one of Austin's most infamous cold cases, showing the emotional aftermath for ...
Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, high-impact therapies in autoimmune diseases and cancer, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results